Skip to content

Effectiveness of homoeopathic medicines in the treatment of dyshidrotic eczema

Role of individualized homoeopathic medicines in the treatment of dyshidrotic eczema using dasi score a prospective and open label clinical study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/03/082054
Enrollment
50
Registered
2025-03-10
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L301- Dyshidrosis [pompholyx]

Interventions

Intervention1: individualised homoeopathic medicine: Detailed and thorough case taking of each and every patient suffering from Dyshidrotic eczema shall be done in accordance with the direction laid d

Sponsors

National Institute of Homoeopathy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Diagnosed and stable patient suffering from Dyshidrotic eczema. 2.Age 5-65 years. 3.All sexes. 4.Patients who can read/ understand English or Hindi or Bengali and if they are not able to read, the physician can help in filling. 5.Providing written informed consent or assent form.

Exclusion criteria

Exclusion criteria: 1.Cases require any immediate surgical intervention or life support measures for any other pathology. 2.Cases suffering from uncontrolled systemic illness or life-threatening infections. 3.Unwilling to take part and not giving consent to join the study. 4.Diagnosed cases of unstable mental or psychiatric illness or other uncontrolled or life-threatening illness affecting quality of life or any organ failure. 5.Pregnant women and lactating mothers 6.Substance abuse and/or dependence. 7.Self-reported immune-compromised state. 8.Undergoing homoeopathic treatment for any chronic disease within last 3 months.

Design outcomes

Primary

MeasureTime frame
The response of the patients to the homoeopathic treatment will be observed and improvement will be assessed by the changes in Dyshidrotic eczema area and severity index (DASI) Timepoint: at the baseline and 6 months

Secondary

MeasureTime frame
The response of the patients to the homoeopathic treatment will be observed & improvement will be assessed by the changes in the Dermatology Life Quality Index (DLQI) Timepoint: at the baseline & 6 months

Countries

India

Contacts

Public ContactDr Gobind Narayan Gupta

National Institute of Homoeopathy

mantoshrath310@gmail.com9777476480

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026